IP Library › Assignment 067839/0134
Patent Assignment
Reel/Frame 067839/0134

Termination and Release of Security Interest in Patents

Recorded: 2024-06-25 Pages: 29
Assignor
BIOPHARMA CREDIT PLC
Executed: 2024-06-25
Assignees
AKEBIA THERAPEUTICS, INC.
245 FIRST STREET, CAMBRIDGE, MASSACHUSETTS, 02142
KERYX BIOPHARMACEUTICALS, INC.
245 FIRST STREET, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Properties (47)
Ferric Citrate Dosage Forms
Application: 16/376,907 →
Publication: US 2020/0215019
Use of Ferric Citrate in the Treatment of Chronic Kidney Disease Patients
Application: 16/154,268 →
Publication: US 2019/0269645
Use of Ferric Citrate in the Treatment of and the Reduction of Mortality and Morbidity Related to Adverse Cardiac Events in Chronic Kidney Disease Patients
Application: 16/216,772 →
Publication: US 2019/0307791
Use of Ferric Citrate in the Treatment of Iron-Deficiency Anemia
Application: 15/553,348 →
Publication: US 2018/0071243
Tablet Containing Ferric Citrate
Application: 16/438,694 →
Publication: US 2020/0163890
Ferric Organic Compounds, Uses Thereof and Methods of Making Same
Application: 16/589,905 →
Pharmaceutical-Grade Ferric Organic Compounds, Uses Thereof and Methods of Making Same
Application: 16/352,455 →
Publication: US 2019/0269722
Iron (Iii) Citrate, Substantially Free of Beta-Iron Hydroxide Oxide
Application: 15/449,132 →
Publication: US 2018/0016220
Pharmaceutical-Grade Ferric Organic Compounds, Uses Thereof and Methods of Making Same
Application: 16/832,101 →
Ferric Citrate Dosage Forms
Application: 16/894,121 →
Publication: US 2020/0297689
Ferric Organic Compounds, Uses Thereof and Methods of Making Same
Application: 16/885,471 →
Iron (Iii) Citrate, Substantially Free of Beta-Iron Hydroxide Oxide
Application: 16/815,472 →
Publication: US 2021/0032186
Pharmaceutical-Grade Ferric Organic Compounds, Uses Thereof and Methods of Making Same
Application: 17/091,090 →
Publication: US 2021/0299168
Ferric Organic Compounds, Uses Thereof and Methods of Making Same
Application: 17/141,765 →
Method of Treating Chronic Kidney Disease
Application: 17/119,554 →
Pharmaceutical-Grade Ferric Organic Compounds, Uses Thereof and Methods of Making Same
Application: 17/350,267 →
Publication: US 2022/0144872
Ferric Organic Compounds, Uses Thereof and Methods of Making Same
Application: 17/405,543 →
Publication: US 2022/0213133
Method of Treating Chronic Kidney Disease
Application: 17/388,361 →
Publication: US 2022/0193022
Use of Ferric Citrate in the Treatment of Iron-Deficiency Anemia
Application: 17/490,195 →
Use of Ferric Citrate in the Treatment of Iron-Deficiency Anemia
Application: 17/743,196 →
Pediatric Formulations of Ferric Citrate
Application: 63/193,938 →
Method of Treating Chronic Kidney Disease
Application: 18/123,053 →
Use of Ferric Citrate in the Treatment of Chronic Kidney Disease Patients
Application: 18/147,240 →
Publication: US 2024/0041816
Use of Ferric Citrate in the Treatment of Iron-Deficiency Anemia
Application: 18/069,555 →
Publication: US 2024/0075006
Use of Ferric Citrate in the Treatment of and the Reduction of Mortality and Morbidity Related to Adverse Cardiac Events in Chronic Kidney Disease Patients
Application: 18/107,928 →
Ferric Citrate Dosage Forms
Application: 18/124,079 →
Ferric Organic Compounds, Uses Thereof and Methods of Making Same
Patent: 7,767,851 →
Application: 11/206,981 →
Publication: US 2006/0020026
Ferric Organic Compounds, Uses Thereof and Methods of Making Same
Patent: 8,338,642 →
Application: 12/711,679 →
Publication: US 2010/0217025
Ferric Organic Compounds, Uses Thereof and Methods of Making Same
Patent: 8,609,896 →
Application: 13/672,900 →
Publication: US 2013/0079537
Ferric Organic Compounds, Uses Thereof and Methods of Making Same
Patent: 8,754,258 →
Application: 14/011,291 →
Publication: US 2013/0345460
Ferric Organic Compounds, Uses Thereof and Methods of Making Same
Patent: 8,901,349 →
Application: 14/011,325 →
Publication: US 2014/0011872
Ferric Organic Compounds, Uses Thereof and Methods of Making Same
Patent: 8,846,976 →
Application: 14/011,357 →
Publication: US 2014/0018420
Ferric Organic Compounds, Uses Thereof and Methods of Making Same
Patent: 9,328,133 →
Application: 14/502,774 →
Publication: US 2015/0232495
Ferric Organic Compounds, Uses Thereof and Methods of Making Same
Patent: 9,913,821 →
Application: 15/143,987 →
Publication: US 2017/0095441
Pharmaceutical-Grade Ferric Organic Compounds, Uses Thereof and Method of Making Same
Patent: 8,093,423 →
Application: 12/064,058 →
Publication: US 2008/0274210
Pharmaceutical-Grade Ferric Organic Compounds, Uses Thereof and Method of Making Same
Patent: 8,299,298 →
Application: 13/289,048 →
Publication: US 2012/0114747
Pharmaceutical-Grade Ferric Organic Compounds, Uses Thereof and Methods of Making Same
Patent: 8,754,257 →
Application: 13/661,558 →
Publication: US 2013/0052261
Pharmaceutical-Grade Ferric Organic Compounds, Uses Thereof and Methods of Making Same
Patent: 9,050,316 →
Application: 14/306,756 →
Publication: US 2014/0309298
Pharmaceutical-Grade Ferric Organic Compounds, Uses Thereof and Methods of Making Same
Patent: 9,757,416 →
Application: 14/701,933 →
Publication: US 2016/0095878
Methods for Treating Renal Failure
Patent: 5,753,706 →
Application: 08/794,328 →
Pharmaceutical-Grade Ferric Citrate
Patent: 6,903,235 →
Application: 10/682,045 →
Publication: US 2005/0080283
Method of Reversing, Preventing, Delaying or Stabilizing Soft Tissue Calcification
Patent: 9,750,715 →
Application: 12/162,558 →
Publication: US 2009/0326060
Method of Treating Chronic Kidney Disease
Application: 15/814,767 →
Publication: US 2018/0133191
Ferric Citrate Dosage Forms
Patent: 9,387,191 →
Application: 13/255,326 →
Publication: US 2012/0115945
Ferric Citrate Dosage Forms
Application: 15/159,008 →
Publication: US 2016/0263075
Iron (Iii) Citrate, Substantially Free of Beta-Iron Hydroxide Oxide
Patent: 9,624,155 →
Application: 14/184,062 →
Publication: US 2015/0025138
Pediatric Formulations of Ferric Citrate
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest May 16, 2007
From: KWOK, DAVID W.K.; STOYNOV, NIKOLAY MINTCHEV
To: PANION & BF BIOTECH, INC.
Reel/Frame 019302/0403 →
Assignment of Assignor's Interest Jan 28, 2013
From: KWOK, DAVID W.K.; STOYNOV, NIKOLAY MINTCHEV
To: PANION & BF BIOTECH, INC.
Reel/Frame 029705/0165 →
Assignment of Assignor's Interest Jan 28, 2013
From: KWOK, DAVID W.K.; STOYNOV, NIKOLAY MINTCHEV
To: PANION & BF BIOTECH, INC.
Reel/Frame 029705/0290 →
Assignment of Assignor's Interest Jan 22, 2014
From: PANION & BF BIOTECH INC.
To: GLOBOASIA LLC
Reel/Frame 032021/0708 →
Assignment of Assignor's Interest Jan 22, 2014
From: KWOK, DAVID W.K.; STOYNOV, NIKOLAY MINTCHEV
To: PANION & BF BIOTECH INC.
Reel/Frame 032021/0338 →
Assignment of Assignor's Interest Jan 22, 2014
From: PANION & BF BIOTECH INC.
To: GLOBOASIA LLC
Reel/Frame 032021/0830 →
Assignment of Assignor's Interest Jan 22, 2014
From: KWOK, DAVID W.K.; STOYNOV, NIKOLAY MINTCHEV
To: PANION & BF BIOTECH INC.
Reel/Frame 032021/0598 →
Nunc Pro Tunc Assignment Jan 22, 2014
From: GLOBOASIA LLC
To: PANION & BF BIOTECH INC.
Reel/Frame 032022/0001 →
Assignment of Assignor's Interest Feb 6, 2014
From: KWOK, DAVID W.K.; STOYNOV, NIKOLAY MINTCHEV
To: PANION & BF BIOTECH INC.
Reel/Frame 032162/0403 →
Nunc Pro Tunc Assignment Feb 6, 2014
From: GLOBOASIA LLC
To: PANION & BF BIOTECH INC.
Reel/Frame 032161/0815 →
Assignment of Assignor's Interest Feb 6, 2014
From: KWOK, DAVID W.K.; STOYNOV, NIKOLAY MINTCHEV
To: PANION & BF BIOTECH INC.
Reel/Frame 032162/0207 →
Assignment of Assignor's Interest Feb 6, 2014
From: KWOK, DAVID W.K.; STOYNOV, NIKOLAY MINTCHEV
To: PANION & BF BIOTECH INC.
Reel/Frame 032160/0729 →
Assignment of Assignor's Interest Feb 6, 2014
From: PANION & BF BIOTECH INC.
To: GLOBOASIA LLC
Reel/Frame 032162/0558 →
Assignment of Assignor's Interest Feb 6, 2014
From: KWOK, DAVID W.K.; STOYNOV, NIKOLAY MINTCHEV
To: PANION & BF BIOTECH INC.
Reel/Frame 032161/0024 →
Assignment of Assignor's Interest Feb 6, 2014
From: PANION & BF BIOTECH INC.
To: GLOBOASIA LLC
Reel/Frame 032162/0761 →
Assignment of Assignor's Interest Feb 6, 2014
From: PANION & BF BIOTECH INC.
To: GLOBOASIA LLC
Reel/Frame 032161/0340 →
Nunc Pro Tunc Assignment Feb 6, 2014
From: GLOBOASIA LLC
To: PANION & BF BIOTECH INC.
Reel/Frame 032162/0964 →
Assignment of Assignor's Interest Feb 6, 2014
From: PANION & BF BIOTECH INC.
To: GLOBOASIA LLC
Reel/Frame 032161/0506 →
Assignment of Assignor's Interest Apr 11, 2017
From: ANDO, KOJI; MANTA, NAOKI
To: JAPAN TOBACCO INC.
Reel/Frame 041962/0858 →
Assignment of Assignor's Interest Feb 21, 2018
From: PORADOSU, ENRIQUE; BENTSUR, RON; SHEMESH, SHAY DAVID
To: KERYX BIOPHARMACEUTICALS, INC.
Reel/Frame 044985/0606 →
Assignment of Assignor's Interest Oct 21, 2019
From: LE, HENRY TRONG
To: KERYX BIOPHARMACEUTICALS, INC.
Reel/Frame 050771/0356 →
Assignment of Assignor's Interest Oct 21, 2019
From: PORADOSU, ENRIQUE; OLIVIERO, III, JAMES F.; BENTSUR, RON
To: KERYX BIOPHARMACEUTICALS, INC.
Reel/Frame 050771/0345 →
Security Interest Nov 26, 2019
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 051119/0089 →
Assignment of Assignor's Interest Dec 17, 2019
From: FUKUSHIMA, MASAYOSHI; ORITA, KAZUHIRO; YAMANE, SHOGO
To: JAPAN TOBACCO INC.
Reel/Frame 051653/0879 →
Security Interest Apr 2, 2020
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 052295/0662 →